Lupin Ltd Drug Patent Portfolio

Lupin Ltd's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Lupin Ltd News

Lupin Challenges Merck! Generic Sugammadex Receives Tentative Approval from the US FDA

31 Mar, 2026

India Experiences Affordable Ozempic Availability - ScoopWhoop

22 Mar, 2026

The patent for Semaglutide is set to expire today. What implications does this have for patients, pharmaceutical companies, and others?

20 Mar, 2026

Indian Pharmaceutical Companies Set to Introduce Generic Semaglutide Following Ozempic Patent Expiration

17 Mar, 2026

See More